Oppenheimer On Upcoming BioMarin Panel: Efficacy Concerns Circulate By: Benzinga via Benzinga November 23, 2015 at 14:30 PM EST Last Friday, the FDA released briefing documents for a BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) meeting regarding drisapersen ... Read More >> Related Stocks: Biomarin Pharmaceuticals